SenesTech Receives Nasdaq Noncompliance Letter; Preliminary Q3 Revenue ~$1.1M
SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced that, on Oct. 20, 2026, it received a letter from the listing qualifications staff of The